Contact Lens Discomfort
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Azura OphthalmicsIsrael - Tel Aviv
1 program1
AZR-MD-001 ointment/semi-solid drugPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AlconSystane Complete
Azura OphthalmicsAZR-MD-001 ointment/semi-solid drug
Clinical Trials (2)
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Start: Nov 2018Est. completion: Mar 2019
Phase 4Completed
Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)
Start: Nov 2022Est. completion: Oct 2023
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space